ICR계 마우스에서 Enrofloxacin과 Colistin 복합체의 단회 경구 및 정맥투여시 급성독성

Acute Toxicity of Enrofloxacin-Colistin Combinations after a Single Oral and Intravenous Administration in ICR Mice

  • 김민규 (충남대학교 수의과대학 약리독성학실험실) ;
  • 박승춘 (한국과학기술원 생명공학연구소) ;
  • 윤효인 (충남대학교 수의과대학 약리독성학실험실) ;
  • 오태광 (한국과학기술원 생명공학연구소) ;
  • 최양웅 ((주)대성미생물연구소)
  • Kim, Min-Kyu (Pharmacol. & Toxicol. Lab., College of Vet. Med., Chungnam National University) ;
  • Park, Seung-Chun (Microbial Enzyme RU, Korea Research institute of Bioscience and Biotechnology) ;
  • Yun, Hyo-In (Pharmacol. & Toxicol. Lab., College of Vet. Med., Chungnam National University) ;
  • Oh, Tae-Kwang (Microbial Enzyme RU, Korea Research institute of Bioscience and Biotechnology) ;
  • Choi, Yang-Woong (Research Lab., Dae Sung Microbiologicals Co., Ltd.)
  • 발행 : 1998.09.01

초록

The study was carried out to evaluate the acute toxicity of enrofloxacin-colistin combination via a single oral(p.o.)and intravenous(i.v.) administration in ICR mice. All procedures of the test were performed by the established regulation of Korean National Institute of Safety Research (1994. 4.14). The maximal dose of oral and intravenous routes was 5,000mg/kg and 90mg/kg, consisting with each 6 groups including control of male and female, respectively. As the results, $LD_{50}$m}'s of the combinations showed 3,075mg/kg (f)and 2,564mg/kg(m) after oral administrations, together with 48mg/kg(f) and 40mg/kg(m) after intravenous administration. These facts indicated that acute toxicitiy of enrofloxacin-colistin combination were different depending on the administration routes and sexes in ICR mice. In conclusion, the route of enrofloxacin-colistin combination must not choose as i.v. route administration in terms of acute toxicity based on $LD_{50}$.

키워드